Cholecystolithiasis
Conditions
Interventions
The sufentanil group (Group S):Thirty minutes before the surgery was completed, sufentanil was injected intravenously at a dose of 0.1 micrograms per kilogram.
The tegrilide group (Group T):Thirty minutes before the surgery was completed, 1 milligram of tegretol was injected intravenously.
Sponsors
The Third People's Hospital Yibin
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients scheduled for day surgery for cholecystectomy; (2) ASA I-III; (3) 18-65 years old.
Exclusion criteria
Exclusion criteria: (1) The patient refused; (2) Patients allergic to tegrilide; (3) Patients who participated in other interventional studies within three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The numerical pain score (NRS) when moving for the first day after the operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| The NRS score at rest on the first day after the operation;The incidence of postoperative nausea;The incidence of postoperative vomiting.;The incidence of postoperative dizziness;The incidence of moderate to severe pain on the first day after surgery;Patient satisfaction with pain control;Quality of Recovery Score (QOR-15) of Postoperative Day 1; | — |
Countries
China
Contacts
Public ContactLi Xiong
The Third People's Hospital Yibin
Outcome results
None listed